| Document |
Document Title |
|
WO/2007/070496A2 |
A process and catalyst blend for selectively producing mercaptans and sulfides from alcohols. The alcohol is reacted with hydrogen sulfide, in the presence of a catalyst blend containing a hydrotreating catalyst and a dehydration catalys...
|
|
WO/2007/068330A1 |
The present invention relates to 2-adamantylurea derivatives of formula (I) as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and the use of such compounds for the treatment and prevention of m...
|
|
WO/2007/064608A1 |
A dihydroxy aromatic compound of Formula (I) (I) wherein R1 is an aromatic divalent functionality having 6 to 60 carbons, R2 can be the same or different at each occurrence and is independently at each occurrence selected from the group ...
|
|
WO/2007/047306A1 |
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal depositi...
|
|
WO/2007/034065A1 |
The invention relates to a method for the continuous preparation of methionine, without the isolation of intermediate products, from the hydantoin of methionine by means of catalyst-free ammonia hydrolysis of an aqueous starting solution...
|
|
WO/2007/034066A1 |
The invention relates to a method of preparing 2-amino-4-(methylthio)butanoic acid (known as methionine) by means of ammonia hydrolysis of an aqueous solution comprising 2-hydroxy-4-(methylthio)butyronitrile (known as HMTBN). The aforeme...
|
|
WO/2007/028708A1 |
The present invention relates to a process for continuously preparing methyl mercaptan from hydrogen sulphide and methanol in direct conjunction with the preparation of hydrogen sulphide.
|
|
WO/2006/125295A1 |
The present invention provides new derivatives of 4-or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4-or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal disea...
|
|
WO/2006/125688A1 |
The invention relates to benzoyl-substituted serine amides of formula (I), in which the variables R1 to R11 are defined as cited in the description and to their salts that can be used for agricultural purposes. The invention also relates...
|
|
WO/2006/125293A1 |
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal dis...
|
|
WO/2006/123521A1 |
A 4-mercaptophenyl ester of acetic acid useful as a material for the synthesis of color developers, etc.; and a process for producing the ester. The 4-mercaptophenyl ester of acetic acid is represented by the formula (1): [Chemical formu...
|
|
WO/2006/108737A1 |
The invention relates to a method for the continuous production of methyl mercaptan by reacting an educt gas mixture comprising methanol and hydrogen sulfide in the gas phase at a reaction temperature ranging from 200 to 600?C and an ope...
|
|
WO/2006/099794A1 |
Derivatives of N-acetyl cysteine and the use thereof are disclosed. The derivatives of N-acetyl cysteine according to the present invention have formula I, wherein POLY are polyalkylene glycols with a molecular weight from 1000Da to 5000...
|
|
WO/2006/093502A1 |
A method is described for the preparation of polymorphic forms of water-soluble derivatives of probucol compounds having the following formula (I) where R1, R2, R3, R4, R5, R6, Z and Z’ are defined herein.
|
|
WO/2006/093501A1 |
A method is described for the preparation of polymorphic forms of water-soluble derivatives of probucol compounds having the following formula (I) where R1, R2, R3, R4, R5, R6, Z and Z’ are defined herein.
|
|
WO/2006/082010A1 |
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein R1, R2, R2´, R3, R4, R5 and X are as defined in the specification and claims. These compounds, and the pharmaceutical compos...
|
|
WO/2006/079480A1 |
The invention relates to the use of thioether derivatives of formula (I) wherein: R1 is an unsubstituted or substituted (C1-C6) alkyl, A is a divalent unit taken from the group CO, CR3(OR4), CR3(O-CO-R4), CR3(COOR4), C(=CR3R4), C(=CR3R4)...
|
|
WO/2006/077170A1 |
The present invention relates to the use of aminodithiols as reducing agents for hair perming. It further relates to a hair perming method using these aminodithiols.
|
|
WO/2006/063408A1 |
The present invention relates to compounds and methods for the treatment of cardiovascular diseases and disorders. Compounds according to the present invention may comprise an optionally substituted phenyl ring linked to an aromatic or a...
|
|
WO/2006/063441A1 |
There is provided compositions comprising a first compound selected from the group consisting of compounds of formulas (I), (III), (V), and (VII), and a second compound selected from the group consisting of compounds of formulas (II), (I...
|
|
WO/2006/058858A2 |
The invention relates to a method for synthesizing organic compounds that are capable of forming a self-organizing monolayer. Said compounds are obtained by reacting an olefin with a thiocarbonic acid and subsequent hydration to give the...
|
|
WO/2006/038741A1 |
Disclosed is an efficient and widely-applicable method for commercially producing a thioether compound or a thiol compound which is useful as a pharmaceutical product or a production intermediate of a pharmaceutical product. Specifically...
|
|
WO/2006/035157A2 |
The invention relates to poly-substituted N-(benzyl)phenylacetamide-type derivatives having formula (I), pharmaceutical compositions containing same and the therapeutic use thereof as PPAR ligands, such as in the human and animal health ...
|
|
WO/2006/035891A1 |
Isonitriles represented by the general formula (1) and antifouling agents against the adhesion of aquatics containing the same: (1) wherein R1 is CH2X (wherein X is hydroxy, halogeno, isocyano, amino, substituted amino, or optionally sub...
|
|
WO/2006/034004A2 |
The present invention is directed to a process for preparing certain cysteine protease inhibitors.
|
|
WO/2006/030875A1 |
Disclosed is a method for producing 4-(methylthio)butane-1,2-diol which is characterized by reacting 3-butene-1,2-diol with methanethiol in the presence of an azo compound such as azonitrile compound, azoester compound, azoamidine compou...
|
|
WO/2006/018718A2 |
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; Forumla (I) and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p3...
|
|
WO/2006/016881A1 |
The invention provides a process for forming diallyl disulfide. The process comprises A) mixing together sulfur and at least one alkali metal sulfide in an initial aqueous medium in which at least about 90 volume percent of said aqueous ...
|
|
WO/2006/014942A1 |
The invention encompasses compounds of Formula (I), including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or...
|
|
WO/2006/003220A1 |
The invention relates to a method of preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles having formula (I), wherein the asterisk (*) represents an asymmetrical carbon and R1 is alkyl C1-C6, the enantiomers or mixtures there...
|
|
WO/2006/000294A1 |
TITLE: The present invention relates to the compounds of the formula (I) to the process for the preparation of them and their therapeutic use, especially their use as antioxidants, as NO generators, and as inhibitors of smooth muscle cel...
|
|
WO/2005/113492A1 |
The invention relates to cysteine analogues salts of Ambroxol represented by formula (I), wherein: n is 1 or 2, A is as defined in the specification. Their preparation methods, pharmaceutical compositions containing them and their uses i...
|
|
WO/2005/102323A2 |
Provided are methods for manufacturing compounds of Formula I wherein all substituents are described herein.
|
|
WO/2005/103030A1 |
The present invention provides small-molecule 1,4-di substituted benzene compounds as non-peptide ligands of cyclophilin A, which have the structure as general formula I. By biological activity tests, it has been indicated that the compo...
|
|
WO/2005/100309A1 |
The present invention provides compounds of the structure (I) wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases such as for example excessive sleepiness, pr...
|
|
WO/2005/082846A1 |
A mixture of dodecanethiol isomers prepared by a method for catalytic reaction of hydrogen sulfide on the trimer of n-butene, having a distillation temperature diagram at 19 millibars such that point 50 is 123 °C at + 1 °C and that the...
|
|
WO/2005/075410A1 |
Compounds of formula (I), for clinical treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection and malignant neoplasia. A pharmaceutical composition comprising a compound of formula (I) in an amount giving a d...
|
|
WO/2005/073158A1 |
The invention relates to compounds having general formula (I), wherein R1 and R2 represent, independently of each other, -OH, or -CH2-O-R3, or -CH2-S-R3, or formula (II), R3, R4, R5 and R6 representing, independently of each other, -H or...
|
|
WO/2005/063780A1 |
Process for the preparation of substituted pyridine derivatives of formula (I) comprising reaction of a &agr -β-unsaturated carbonyl compound of formula (II) R3-C(O)-C(R1)=C(R2)-G with a Wittig reagent or Horner-Wadsworth-Emmons reagent...
|
|
WO/2005/058809A1 |
The invention relates to a method for the separation of methyl mercaptan from reaction gas mixtures obtained by means of the catalytic conversion of H2S with methanol, by means of converting the methyl mercaptan into MMP in the presence ...
|
|
WO/2005/049870A1 |
The invention relates to a method for the extraction of keratin from dead animal skins, characterised in the treatment of dead animal skins with a substance of general formula (I), or at least one corresponding alkali metal, earth alkali...
|
|
WO/2005/047237A1 |
The invention relates to a method for synthesising, in an industrialised solid phase, novel diaryl sulphide compounds of formula (I). Said invention also relates to the purity of novel industrial useful products, to chemical compounds pr...
|
|
WO/2005/040082A2 |
The present invention refers to a continuous process for the manufacture of methyl mercaptan using Mo-O-K-based catalysts. It is further described that the total selectivity of methylmercaptan can be increased by at least 1% by lowering ...
|
|
WO/2005/033070A2 |
The invention relates to a method for the production of bisepoxides, characterised in that a conjugated diene of formula (I) is reacted with at least one peroxide with the application of up to 4 equivalents of peroxide per C-C double bon...
|
|
WO/2005/030710A1 |
The invention relates to a low-odour tert-dodecanethiol which is particularly suitable as a molecular weight regulator and which can be obtained by acidic catalytic addition of hydrogen sulphide to a hydrocarbon mixture, comprising 10 - ...
|
|
WO/2005/021491A1 |
The invention relates to an oxidic catalyst, which contains cesium and tungsten, for synthesizing alkanethiols from alkanols and hydrogen sulfide, and to a method for producing this catalyst, whereby the molar ratio of cesium to tungsten...
|
|
WO/2004/103957A1 |
A novel compound of formula (I) and a process for the preparation of compounds of formula (I): by reacting a compound of formula (II): Formula (III): with a compound of formula (III) where R1 and R2 are any suitable alkyl group, preferab...
|
|
WO/2004/096760A1 |
The invention relates to a catalyst for synthesizing methyl mercaptan from hydrogen sulfide and methanol, and a method for producing said methyl mercaptans. The inventive catalyst comprises active aluminum oxide on which alkaline tungsta...
|
|
WO/2004/094522A2 |
Compounds and polymers of such compounds are prepared based on the reaction product of a polysulfide containing diol and a dibasic acid, conveniently using an acid catalyst for the reaction. By appropriate choice of mole ratios, the resu...
|
|
WO/2004/071504A1 |
The invention relates to novel compounds which correspond to the general formula (I), their method of preparation, and their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology and in the f...
|
